Breast Cancer: Professionals To Brainstorm On The Use Of The NCCN Harmonised Guidelines

Breast Cancer: Professionals To Brainstorm On The Use Of The NCCN Harmonised Guidelines

All plans are underway for Health experts across the country to identify and explore the barriers and facilitators in the use of the Harmonised National Comprehensive Cancer Network (NCCN) guidelines in Nigeria at the upcoming one-day symposium on breast cancer organised by the Association of Radiation and Clinical Oncologist of Nigeria (ARCON). BLUEPRINTS reports.

The one-day symposium themed: “Optimizing the Standard of Care for Breast Cancer in Nigeria” will hold on the 30th of June, 2022 in Enugu State. Information Guide Nigeria

See Other Top News:

In a press release presented by Dr Nwamaka Lasebikan, the President of ARCON yesterday explained that the meeting will be hybrid to allow for maximum participation of key stakeholders offering care in the Oncology space. jamb results

She further explained that established in 2016, ARCON is a community of more than 100 professionals (specialist and trainees) with the aim of promoting ethical and evidence-based standard of care for cancer in our environment and aims to develop robust and competent cancer health solutions together with the government of Nigeria.

” Some of our objectives are to liaise with international bodies with similar goals, sensitize the Nigerian population about cancer and ways to combat the scourge and stigma, as well as encourage and advance the knowledge and practice of the science of Radiation and Clinical Oncology through Research, Education & Training, and knowledge dissemination via CMEs, Conferences, Workshops amongst others.

“Breast cancer is the most common cancer in women worldwide, however, the mortality rate and probability of surviving for up to or more than 5years in lower and middle-income countries like Nigeria falls short of what obtains in high-income countries.

“With the rapid advancement of new technologies and medications, this disparity continues to increase with clinical and patient outcomes related to the side of the globe you live in.

“This one-day symposium will feature lectures and panelist sessions from seasoned experts in oncology in a bid to close the care gap, improve clinical outcomes and quality of life of patients with breast cancer,” she said.

This post can be helpful to somebody else, please share it on Facebook, Whatsapp, Telegram and Twitter. There are buttons below for this (easy to use too)!

Copyright Warning!

Contents on this website may not be republished, reproduced, redistributed either in whole or in part without due permission or acknowledgment.

Proper acknowledgment includes, but not limited to (a) LINK BACK TO THE ARTICLE in the case of re-publication on online media, (b) Proper referencing in the case of usage in research, magazine, brochure, or academic purposes,.

All contents are protected by the Digital Millennium Copyright Act 1996 (DMCA).

We publish all contents with good intentions. If you own this content & believe your copyright was violated or infringed, please contact us at [] to file a complaint and we will take necessary actions immediately.

🤑 Start making money from home today!

👉 Get correct FREE TIPS and Guides on how to make money from home today. Click here to start



👍Advertise your business here!

With over 1M unique users per month across all channels, we have a large audience for you to showcase your products and services. Simply get in touch via 👉


🤑 Make Money now!

👉 Make money writing for us. Apply for Freelance writing jobs in Nigeria.

👉 Make Money as InfoGuideNigeria Advertising Agents, read more here



Essien, Goodnews is a gruaduate of Communication Arts, University of Uyo, Uyo; Currently working at Infoguide Media as a news writer.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

It looks like you're using an ad blocker!

This website is maintained by the advertising revenue and we noticed you have ad-blocking enabled. Please disable Ad-Blocker